| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 5702280 | Practical Radiation Oncology | 2017 | 23 Pages |
Abstract
Nearly 95% of patient treatments deviated from the ICRU-83 recommended D50 prescription dose delivery. This variability is significant (P < .01) in terms of treatment site, technique, and institution. To reduce dosimetric and associated radiation outcome variability, dose prescription in every clinical trial should be unified with international guidelines.
Related Topics
Health Sciences
Medicine and Dentistry
Oncology
Authors
Indra J. PhD, FACR, FASTRO, Aaron MS, Zhe (Jay) PhD, Andrea MS, Eli MD, FASTRO, Jeremy PhD, Long PhD, Mark P. MD, Choonik PhD, Matthew MS, Richard A. PhD, Roger PhD, Jennifer PhD, Patricia MS, Timothy PhD,